What Immunochemistry Technologies does

Immunochemistry Technologies (ICT) is a private life-sciences reagent brand, founded in 1994 and operated as a product line within Antibodies Incorporated, a Davis, California-based parent company in operation for over fifty years. ICT manufactures and distributes a 307-product catalog of cell viability, apoptosis, autophagy, oxidative stress, caspase, and cathepsin assay kits, alongside ELISA buffers and reagents, IHC reagents, antibodies, dyes, tracers, IVD kit components, proteins/peptides, and custom services such as antibody development, adenovirus production, and contract manufacturing. The platform rests on two proprietary chemistry systems: FLICA (Fluorescent-Labeled Inhibitors of Caspases) fluorescent caspase probes and Magic Red fluorogenic cathepsin substrates, with parallel offerings in oxidative stress, MitoPT (mitochondrial), and FLISP intracellular protease assays — all produced at an ISO-13485-certified facility in Davis, California.

The business operates a dual go-to-market: product-led growth through the Antibodies Incorporated e-commerce storefront (where catalog SKUs are priced publicly from roughly $7.65 for basic plates to $358.70 for specialized kits), and channel-based distribution through an international distributor network explicitly surfaced via a 'Find a distributor near you' portal. GTM is supplemented by trade-show presence (ADLM in Anaheim — Booth 1944 — and AACR), monthly email newsletters, and an extensive protocol-and-citation educational content library serving as top-of-funnel scientific marketing. Customer demand is served horizontally across two segments: life-science researchers in academia and industry using assays for apoptosis, autophagy, oxidative stress, and ELISA development; and pharmaceutical/biotech buyers employing the same tools for drug discovery, target validation, and preclinical screening, with custom services addressing higher-margin needs.

Revenue mechanics consist of one-time sales of catalog research kits and reagents alongside higher-margin contract services (custom antibody development, antibody conjugation/purification, ELISA/immunoassay services, custom buffer manufacturing, adenovirus production). The firm reports no public funding rounds, no M&A activity, and no disclosed headcount; its scale is consistent with a profitable, privately-held sub-brand operating within a larger parent portfolio that also includes the Antibodies Inc./NeuroMab, Aves Labs, Biosensis, and PhosphoSolutions brands.

Name

Immunochemistry Technologies

Legal name

Immunochemistry Technologies

Website

https://immunochemistry.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Immunochemistry Technologies, a brand under Antibodies Incorporated founded in 1994, manufactures and distributes cell viability, apoptosis, caspase, cathepsin, and ELISA assay kits and reagents from an ISO-13485 facility in Davis, California, serving academic life-science researchers and pharmaceutical/biotech customers globally via e-commerce and a worldwide distributor network.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Cell viability assays
• Fluorescent caspase assays
• ELISA reagents
• Immunohistochemistry reagents
• Research assay kits

Headquarters

HQ city

Bloomington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Research Assay Kits and Reagents: Sale of cell viability assay kits (FLICA, Magic Red), ELISA reagents and development kits, IHC reagents, and biochemical reagents. Products are sold directly through the Antibodies Inc. e-commerce platform and through a global distributor network.
2. Custom Antibody and Assay Services: Contract services including custom antibody development, antibody conjugation and purification, ELISA/immunoassay services, and custom buffer manufacturing. These services complement product sales and provide higher-margin revenue streams.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Immunochemistry Technologies manufactures and sells fluorescent whole-cell assay kits (including FLICA caspase assays, Magic Red cathepsin assays, and oxidative stress assays), ELISA development reagents (blocking buffers, wash buffers, substrates, coating buffers, diluents), and immunohistochemistry reagents. The company also offers custom antibody development, adenovirus production, and contract manufacturing services, all produced at an ISO-13485-certified facility in Davis, California, and distributed worldwide through Antibodies Incorporated.

Product overview

Immunochemistry Technologies is a laboratory reagent and assay kit manufacturer operated by Antibodies Incorporated, producing a comprehensive portfolio of products for cell viability research, ELISA development, and immunohistochemistry. The company's core offerings center on fluorescent whole cell assay kits (including FLICA caspase assays, Magic Red cathepsin assays, and oxidative stress assays), ELISA reagents (blocking buffers, wash buffers, substrates, conjugates, diluents, and coating buffers), and IHC reagents (antigen retrievers, chromogens, mounting media). The product line extends to custom antibody development services, adenovirus production services, and contract manufacturing, all produced at an ISO-13485-certified facility in Davis, California. With 307 products catalogued, the portfolio spans from individual reagents and consumables to complete assay kits and integrated custom service offerings, serving life science research and in vitro diagnostics development markets.

Differentiator

Problem solved

Functional benefit

Brands

• FLICA®: Fluorescent caspase assay kits for apoptosis detection
• Magic Red®
• MitoPT
• FLISP
• Neptune Block
• SynBlock
• TMB Super Sensitive

Products and services

• Magic Red® Fluorescent Cathepsin B Assay Kit Fluorescent whole cell assay kit for detecting cathepsin B activity in live cells, used for lysosomal protease research and cellular imaging applications.
• FAM-FLICA® Caspase-1 (YVAD) Assay Kit Green fluorescent assay kit for detecting caspase-1 activity, used in pyroptosis research and inflammasome studies.
• FAM-FLICA® Caspase-9 (LEHD) Assay Kit Green fluorescent assay kit for detecting caspase-9 activity in apoptotic pathways, validated in breast cancer cell research.
• FAM-FLICA® Caspase-3/7 (DEVD) Assay Kit Green fluorescent assay kit for detecting caspase-3 and caspase-7 activity, used for detecting apoptosis in various cell types including neurons.
• FLICA® 660 Caspase-1 (YVAD) Assay Kit Far-red fluorescent assay kit for caspase-1 detection, enabling multiplexed analysis with green fluorophores.
• Pyroptosis/Caspase-1 Assay - Green Fluorescent Specialized assay for detecting pyroptotic cell death through caspase-1 activation, used in infectious disease research.
• ELISA Reagent Suite Comprehensive suite of ELISA development components including coating buffers, blocking buffers (General Block, SynBlock, Neptune Block, Monster Block, Alternative Block), wash buffers, sample diluents, HRP conjugate stabilizers, TMB substrates, and stop solutions.
• IHC Reagents Immunohistochemistry reagents including antigen retrievers, blocking reagents, buffers, chromogens, counter stains, detergents, IHC kits, lectins, mounting media, and protein-fluorophore conjugates.
• Immulon™ 2 HB 96-Well Microtiter EIA Plate 96-well microtiter plate for enzyme immunoassays, providing a solid phase for antibody or antigen immobilization.
• Custom Antibody Development Services Contract services including polyclonal chicken IgY production, mouse monoclonal development, phosphospecific antibody development, recombinant antibody development, hybridoma scale-up, anti-drug antibody controls, antibody conjugation, and antibody purification.
• ELISA / ImmunoAssay Services Contract ELISA and immunoassay development services for custom assay development.
• Adenovirus Production Services Complete adenovirus production services including RAPAd technology, dual expresser production, amplification, purification, and quality control.
• Contract Manufacturing Services Contract manufacturing services for antibody and reagent production, plus custom buffer formulation and custom peptide synthesis.
• Oxidative Stress Assays Whole cell fluorescent assays for detecting and measuring oxidative stress in cellular samples, used in cell viability and metabolism research.
• IVD Kits and Components In vitro diagnostic kits and components for clinical laboratory applications.
• Dyes & Tracing Reagents Specialized dyes and tracers including axonal tracers, amyloid stains, nerve terminal dyes, ion channel probes, fluorescent calcium indicators, lipid tracers, myelin biology reagents, and Nissl stains.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Cayman Chemical: Direct peer in biochemical reagents, assay kits, ELISA reagents, and small molecules serving academic and pharma researchers. Overlaps in ELISA buffers/substrates and cell biology assay categories.
• Enzo Life Sciences: Direct peer specializing in apoptosis, oxidative stress, and cell biology assay kits. Its caspase and protease assay lines overlap directly with ICT's FLICA and Magic Red platforms.
• Cell Signaling Technology: Direct peer specializing in antibodies and reagents for cell biology, including apoptosis and caspase assays. Overlaps directly with ICT's FLICA caspase kits and broader cell death pathway reagents, serving the same academic and pharma R&D customers.
• Bio-Rad Laboratories: Direct peer offering a broad life science research portfolio including apoptosis kits, ELISA reagents, IHC reagents, and antibodies. Competes across most of ICT's product categories with greater scale and a global commercial footprint.
• Santa Cruz Biotechnology: Direct peer in research antibodies, ELISA reagents, and cell biology products. Competes with ICT in primary/secondary antibodies and select apoptosis-related reagents for the academic research market.
• Abcam: Direct peer in research-grade antibodies, ELISA kits, and cell biology reagents, with deep overlap in primary/secondary antibodies, IHC, and ELISA reagent categories where ICT competes.

Broad incumbents

• BD Biosciences: Broad incumbent in flow cytometry, cell biology, and apoptosis detection assays. Its Annexin V and caspase assay products overlap with ICT's FLICA kits, particularly for flow cytometry applications.
• Thermo Fisher Scientific: Broad incumbent in life sciences with an extensive catalog of antibodies, ELISA kits, IHC reagents, cell viability assays, and custom services. Competes with ICT across nearly every product category but as part of a vastly larger portfolio.
• Bio-Techne (R&D Systems / Novus Biologicals): Broad incumbent in research reagents, ELISA kits, antibodies, and cell biology assays under the R&D Systems and Novus Biologicals brands. Overlaps with ICT in ELISA development reagents and antibody products.
• Sigma-Aldrich (Merck KGaA): Broad incumbent offering one of the largest catalogs of biochemicals, antibodies, ELISA reagents, and cell biology kits. Competes with ICT in commodity reagents and consumables where scale advantages matter.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ImmunoChemistry
• Facebookfacebook.com/ImmunoChemistryTechnologies
• LinkedInlinkedin.com/company/immunochemistry-technologies-llc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immunochemistry Technologies